Neurenati Therapeutics
Biotechnology Research • 
630 Boul René-Lévesque West 20th floor, Montreal, Canada • 1-10 Employees
Company overview
| Headquarters | 630 Boul René-Lévesque West 20th floor, Montreal, Quebec H3B 1S6, CA |
| Phone number | +15148259035 |
| Website | |
| NAICS | 541714 |
| Keywords | Rare Diseases, Pediatric, Neurosciences, Gastroenterology, Neuro-Regeneration, Hirschsprung |
| Founded | 2020 |
| Employees | 1-10 |
| Socials |
Key Contacts at Neurenati Therapeutics
Marielle Cohard-Radice
Independent Director
Geneviève Gaucher
Senior Director, Preclinical Development
Neurenati Therapeutics Email Formats
Neurenati Therapeutics uses 2 email formats. The most common is {first initial} (e.g., j@neurenati.com), used 57.1% of the time.
| Format | Example | Percentage |
|---|---|---|
{first initial} | j@neurenati.com | 57.1% |
{first name} | john@neurenati.com | 42.9% |
About Neurenati Therapeutics
Neurenati develops novel therapies for GI rare pediatric diseases
Neurenati Therapeutics revenue & valuation
| Annual revenue | $769,995 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $2,500,000 |
| Total funding | $2,584,400 |
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Employees by Department
Neurenati Therapeutics has 4 employees across 3 departments.
Departments
Number of employees
Funding Data
Explore Neurenati Therapeutics's funding history, including investment rounds, total capital raised, and key backers.
Neurenati Therapeutics Tech Stack
Discover the technologies and tools that power Neurenati Therapeutics's digital infrastructure, from frameworks to analytics platforms.
Security
JavaScript libraries
Maps
JavaScript libraries
JavaScript libraries
CDN
Font scripts
JavaScript libraries
Programming languages
Blogs
UI frameworks
Israel
IndiaFrequently asked questions
4.8
40,000 users
